ORIC Pharmaceuticals, Inc.
CD73 INHIBITORS
Last updated:
Abstract:
Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of cancer, infections, and neurodegenerative diseases.
Status:
Application
Type:
Utility
Filling date:
23 Oct 2020
Issue date:
18 Feb 2021